KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Revenue (2020 - 2025)

Historic Revenue for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Q3 2025 value amounting to $38.8 million.

  • Ginkgo Bioworks Holdings' Revenue fell 5638.55% to $38.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $180.6 million, marking a year-over-year decrease of 1713.46%. This contributed to the annual value of $227.0 million for FY2024, which is 970.83% down from last year.
  • Ginkgo Bioworks Holdings' Revenue amounted to $38.8 million in Q3 2025, which was down 5638.55% from $49.6 million recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' 5-year Revenue high stood at $168.4 million for Q1 2022, and its period low was $34.8 million during Q4 2023.
  • For the 5-year period, Ginkgo Bioworks Holdings' Revenue averaged around $74.0 million, with its median value being $56.2 million (2024).
  • In the last 5 years, Ginkgo Bioworks Holdings' Revenue surged by 48344.61% in 2021 and then crashed by 6463.86% in 2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Revenue (Quarter) stood at $148.5 million in 2021, then plummeted by 33.81% to $98.3 million in 2022, then plummeted by 64.64% to $34.8 million in 2023, then rose by 26.16% to $43.8 million in 2024, then decreased by 11.43% to $38.8 million in 2025.
  • Its last three reported values are $38.8 million in Q3 2025, $49.6 million for Q2 2025, and $48.3 million during Q1 2025.